← All trials
NCT01832363
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2013
- Primary completion
- Aug 1, 2017
- Completion date
- Aug 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Xemed LLCLead sponsor
- Xemed LLCOverall official - principal investigator
- University of VirginiaOverall official - principal investigator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- University of VirginiaCollaborator
- Washington University in St. LouisOverall official - principal investigator
- Washington University in St. LouisCollaborator
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.